BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 32142853)

  • 1. MiR-328-3p inhibits cell proliferation and metastasis in colorectal cancer by targeting Girdin and inhibiting the PI3K/Akt signaling pathway.
    Pan S; Ren F; Li L; Liu D; Li Y; Wang A; Li W; Dong Y; Guo W
    Exp Cell Res; 2020 May; 390(1):111939. PubMed ID: 32142853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-125a-3p/FUT5-FUT6 axis mediates colorectal cancer cell proliferation, migration, invasion and pathological angiogenesis via PI3K-Akt pathway.
    Liang L; Gao C; Li Y; Sun M; Xu J; Li H; Jia L; Zhao Y
    Cell Death Dis; 2017 Aug; 8(8):e2968. PubMed ID: 28771224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells.
    Lu J; Zhang L; Zhou H; Du Z; Zhang G
    Oncol Rep; 2018 Aug; 40(2):887-894. PubMed ID: 29989653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor of DNA binding 2 knockdown inhibits the growth and liver metastasis of colorectal cancer.
    Liu F; Chen S; Yu Y; Huang C; Chen H; Wang L; Zhang W; Wu J; Ye Y
    Gene; 2022 Apr; 819():146240. PubMed ID: 35114275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
    Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-144-3p inhibits the proliferation and metastasis of pediatric Wilms' tumor cells by regulating Girdin.
    Liu CL; Wang WH; Sun YL; Zhuang HW; Xu M; Chen HF; Liu JX
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7671-7678. PubMed ID: 30536309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-760 inhibits the biological progression of colorectal carcinoma by directly targeting FOXA1 and regulating epithelial-to-mesenchymal transition and PI3K/AKT signaling pathway.
    Cong K; Li CG; Wei YH; Zhang K; Xu HB
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5730-5740. PubMed ID: 31298352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma.
    Liang Z; Liu Z; Cheng C; Wang H; Deng X; Liu J; Liu C; Li Y; Fang W
    Cell Death Dis; 2019 Apr; 10(4):305. PubMed ID: 30944308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway.
    Lv X; Li CY; Han P; Xu XY
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2321-2327. PubMed ID: 29762835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer.
    Zhao D; Sui Y; Zheng X
    Oncol Rep; 2016 Feb; 35(2):1075-82. PubMed ID: 26718987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
    Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
    Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling.
    Chen X; Wang W; Li Y; Huo Y; Zhang H; Feng F; Xi W; Zhang T; Gao J; Yang F; Chen S; Yang A; Wang T
    J Exp Clin Cancer Res; 2021 Oct; 40(1):341. PubMed ID: 34706761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxypeptidase A6 suppresses the proliferation and invasion of colorectal cancer cells and is negatively regulated by miR-96-3p.
    Wang X; Liu F; Cui Z; Li Z; Lv Y
    Arch Biochem Biophys; 2023 May; 740():109595. PubMed ID: 37011707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor miR-1 restrains epithelial-mesenchymal transition and metastasis of colorectal carcinoma via the MAPK and PI3K/AKT pathway.
    Xu L; Zhang Y; Wang H; Zhang G; Ding Y; Zhao L
    J Transl Med; 2014 Sep; 12():244. PubMed ID: 25196260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lncRNA XIST/miR-125b-2-3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancer.
    Zeng ZL; Lu JH; Wang Y; Sheng H; Wang YN; Chen ZH; Wu QN; Zheng JB; Chen YX; Yang DD; Yu K; Mo HY; Hu JJ; Hu PS; Liu ZX; Ju HQ; Xu RH
    Cancer Med; 2021 Apr; 10(7):2423-2441. PubMed ID: 33666372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
    Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
    J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-140-3p inhibits colorectal cancer progression and its liver metastasis by targeting BCL9 and BCL2.
    Liu D; Chen C; Cui M; Zhang H
    Cancer Med; 2021 May; 10(10):3358-3372. PubMed ID: 33838016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.